Experience of mycophenolate mofetil in 10 patients with autoimmune-related interstitial lung disease demonstrates promising effects.
about
Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective reviewTreatment of inflammatory myopathy: emerging therapies and therapeutic targetsRecent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory MyopathiesUp-to-Date Information on Rheumatoid Arthritis-Associated Interstitial Lung DiseaseTreatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendationsMycophenolate mofetil for interstitial lung disease in dermatomyositis.Safety and effectiveness of mycophenolate in systemic sclerosis. A systematic reviewSystemic sclerosis disease modification clinical trials design: quo vadis?Connective Tissue Disease-associated Interstitial Lung Disease: A review.Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease.Therapeutic approaches in myositis.Interstitial Lung Disease in Idiopathic Inflammatory Myopathy.Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment.Update on the pharmacological treatment of adult myositis.Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review.Recent developments on treatment strategies and the prognosis of dermatomyositis: a review.[Interstitial lung disease in polymyositis/dermatomyositis].The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s SyndromeAmyopathic dermatomyositis with lung involvement responsive to mycophenolate mofetil
P2860
Q26775753-0375BB16-66C6-4073-9A47-93C325E5EE6EQ26796546-EFBACD60-93CF-4631-BA57-DCBCA1AFAE22Q26798023-C87FB5B8-14C7-4668-B0E3-6B555CA090ABQ26825098-9A7B6A1A-4E28-453F-BAAA-2F481615C4B7Q33907242-EECB39A9-FC2E-46C3-95E1-6A9F01CF7DF9Q34443730-95B9EA96-028C-4655-89E9-7CFA1799C1C4Q34904088-056AC051-45D2-4F9F-B763-33A6085FE7BBQ35560664-697D6C85-A306-45A5-9DF3-34FED5B3AA28Q36067226-34E0C12D-5F47-440C-8D16-7740E1D43901Q36363696-A8C7B310-7B39-4AF8-AD47-BD61196FD3ABQ36913821-C04ADB43-0560-4E3D-BEE2-664331C12AEEQ37848694-F9138B84-3D6E-4CBD-9108-5C6D17B2607EQ37937430-62891A50-F796-4730-979D-ED22A97F1E2BQ37988393-D7FFF28A-39FA-4EA4-9E9E-F344C9B9763FQ38813275-B84F3A34-6823-4E42-A113-63A3C90743D2Q39147131-73A1D9B5-1E1A-4596-B2BB-10BE234B219CQ47436112-A56580A0-FCD7-4C15-A27E-D77BC0AED4D6Q53114551-46968114-AF09-4337-BCC2-6F515F7FF740Q55970269-68EA80EC-3C1B-4EAD-BC78-E1F3679A0B1AQ59221120-AEA1996C-8CA3-447B-966C-4B75DD52B405
P2860
Experience of mycophenolate mofetil in 10 patients with autoimmune-related interstitial lung disease demonstrates promising effects.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Experience of mycophenolate mo ...... emonstrates promising effects.
@en
Experience of mycophenolate mo ...... emonstrates promising effects.
@nl
type
label
Experience of mycophenolate mo ...... emonstrates promising effects.
@en
Experience of mycophenolate mo ...... emonstrates promising effects.
@nl
prefLabel
Experience of mycophenolate mo ...... emonstrates promising effects.
@en
Experience of mycophenolate mo ...... emonstrates promising effects.
@nl
P1476
Experience of mycophenolate mo ...... emonstrates promising effects.
@en
P2093
Lesley Ann Saketkoo
Luis R Espinoza
P304
P356
10.1097/MAJ.0B013E31818D094B
P407
P577
2009-05-01T00:00:00Z